abagovomab 55
abciximab 51
abituzumab 36
abrilumab 34
actoxumab 35
adalimumab 26
aducanumab 20
afasevikumab 23
alacizumab_pegol 17
alemtuzumab 45
alirocumab 26
amatuximab 62
andecaliximab 38
anifrolumab 39
anrukinzumab 23
aprutumab 25
aprutumab_ixadotin 25
arcitumomab 38
ascrinvacumab 28
atezolizumab 17
atinumab 25
avelumab 22
basiliximab 57
bavituximab 59
begelomab 56
benralizumab 43
bevacizumab_beta 27
bezlotoxumab 35
bimagrumab 38
bleselumab 38
blinatumomab 56
blosozumab 42
bococizumab 35
brazikumab 28
brentuximab_vedotin 53
briakinumab 26
brodalumab 36
brolucizumab 32
brontictuzumab 40
burosumab 38
cabiralizumab 43
camrelizumab 17
canakinumab 28
cantuzumab_ravtansin 66
carlumab 35
carotuximab 45
cergutuzumab_amunaleukin2 42
cergutuzumab_amunaleukin 42
certolizumab_pegol 30
cetiximab 56
citatuzumab_bogatox 34
cixutumumab 53
clivatuzumab_tetraxetan 42
codrituzumab 42
conatumumab 29
concizumab 36
crenezumab 25
crizanlizumab 38
crotedumab 30
dacetuzumab 28
daclizumab 34
dalotuzumab 49
dapirolizumab_pegol 31
daratumumab 19
dectrekumab 15
demcizumab 44
denosumab 13
depatuxizumab 40
depatuxizumab_mafodotin 40
dezamizumab 39
dinutuximab 54
diridavumab 40
domagrozumab 20
drozitumab 27
duligotuzumab 22
durvalumab 18
dusigitumab 39
efalizumab 40
efungumab 44
eldelumab 26
elezanumab 43
elgemtumab 16
elotuzumab 26
emactuzumab 37
emapalumab 33
emibetuzumab 34
enavatuzumab 30
enfortumab_vedotin 19
enoblituzumab 28
enokizumab 37
enoticumab 28
ensituximab 59
eptinezumab 24
erenumab 34
etaracizumab 19
etrolizumab 26
evinacumab 27
evolocumab 38
farletuzumab 18
fasinumab 37
fezakinumab 46
fibatuzumab 32
ficlatuzumab 39
firivumab 48
flanvotumab 35
fletikumab 48
foralumab 22
foravirumab 20
fremanezumab 36
fresolimumab 32
fulranumab 25
futuximab 48
galcanezumab 32
ganitumab 46
gantenerumab 21
gemetuzumab 48
gemtuzumab2 44
gemtuzumab 53
gevokizumab 38
girentuximab 41
glembatumumab 41
glembatumumab_vedotin 41
guselkumab 41
ibalizumab 40
ibritumomab 63
icrucumab 22
idarucizumab 54
ifabotuzumab 32
imalumab 20
imgatuzumab 38
inclacumab 27
indatuximab_ravtansin 48
indusatumab 34
inebilizumab 33
intetumumab 21
iodine_girentuximab 34
ipilimumab 14
iratumumab 34
isatuximab 47
itolizumab 34
ixekizumab 47
labetuzumab_govitecan 30
lambrolizumab 43
lampalizumab 35
lanadelumab 22
landogrozumab 23
laprituximab 46
lebrikizumab 50
lendalizumab 40
lenzilumab 37
lifastuzumab_vedotin 28
ligelizumab 36
lilotomab 51
lirilumab 44
lodelcizumab 37
lokivetmab 30
lorvotuzumab_mertansin 31
lucatumumab 36
lumretuzumab 34
lupartumab 24
lutikizumab 26
margetuximab 47
milatuzumab 52
mirvetuximab 52
mirvetuximab_soravtansin 52
modotuximab 64
mogamulizumab 36
monalizumab 39
motavizumab 47
moxetumomab_pasudotox 36
namilumab 44
naratuximab 50
naratuximab_emtansin 50
narnatumab 23
navicixizumab2 39
navicixizumab 45
navivumab 52
necitumumab 30
nemolizumab 42
nesvacumab 21
nivolumab 22
obiltoxaximab 41
obinutuzumab 48
ocaratuzumab 41
ofatumumab 28
olaratumab 38
olokizumab 30
omalizumab 26
onartuzumab 26
ontuxizumab 46
opicinumab 20
orticumab 22
otelixizumab 41
oxelumab 16
ozanezumab 48
pamrevlumab 16
panobacumab 34
parsatuzumab 34
pasotuxizumab 24
pateclizumab 24
patritumab 39
pembrolizumab 43
perakizumab 28
pidilizumab 36
pinatuzumab_vedotin 23
plozalizumab 37
pogalizumab 40
polatuzumab_vedotin 26
ponezumab 54
prezalumab 19
pritoxaximab 60
quilizumab 22
racotumomab 47
radretumab 21
ralpancizumab 37
ramucirumab 20
ranevetmab 37
ranibizumab 30
refanezumab 32
remtolumab 23
rilotumumab 35
rinucumab 36
risankizumab 44
rituximab 50
rivabazumab 30
robatumumab 23
roledumab 39
romosozumab 38
rontalizumab 30
rosmantuzumab 40
rozanolixizumab 28
sacituzumab 41
sacituzumab_govitecan 41
samalizumab 40
sapelizumab 39
sarilumab 22
secukinumab 25
seribantumab 21
setoxaximab 60
sifalimumab 32
siltuximab 44
simtuzumab 46
sirukumab 20
solanezumab 30
solitomab 43
stamulumab 39
suptavumab 34
suvizumab 28
tabalumab 34
tadocizumab 34
tamtuvetmab 42
tanezumab 38
tarextumab 17
tavolixizumab 35
telisotuzumab 45
teplizumab 33
tesidolumab 45
tezepelumab 38
tigatuzumab 20
tildrakizumab 37
timolumab 23
tisotumab 18
tosatoxumab 54
tositumomab 60
tralokinumab 50
trastuzumab 27
tregalizumab 29
trevogrumab 24
ublituximab 54
urelumab 38
ustekinumab 39
utomilumab 42
vadastuximab 43
vadastuximab_talirin 43
vandortuzumab_vedotin 26
vantictumab 30
vanucizumab2 27
vanucizumab 58
varlilumab 21
vatelizumab 43
vedolizumab 45
veltuzumab 39
vesencumab 16
vorsetuzumab 38
vorsetuzumab_mafodotin 38
vunakizumab 51
xentuzumab 28
zatuximab 64
